Literature DB >> 24515844

The documentation of consent and disclosure of neurogenetic testing outside clinical genetics.

C Lo1, J Martindale, M Hadjivassiliou, P Martin, A Dalton, O Bandmann.   

Abstract

Neurogenetic tests are increasingly requested by clinical neurologists without any formal training in clinical genetics. The aim of our study was to assess the documentation of consent and disclosure of genetic test results in a large regional clinical neuroscience centre. Documentation of some form of consent was evident in only 26/132 (20 %) of tests. However, the higher proportion of both positive and negative results disclosed (50/132, 38 %) suggest that the former figure may underestimate actual rates of undocumented consent within the clinical setting. Our findings highlight the need for a review of established practices surrounding consent in clinical neurology.

Mesh:

Year:  2014        PMID: 24515844     DOI: 10.1007/s10048-014-0391-3

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  2 in total

1.  Genomic medicine and neurology.

Authors:  Jeffery M Vance; Demet Tekin
Journal:  Continuum (Minneap Minn)       Date:  2011-04

2.  Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes.

Authors: 
Journal:  Eur J Hum Genet       Date:  2010-08-25       Impact factor: 4.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.